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Introduction
The term 'extracellular vesicles' (EVs) defines a heterogeneous family of cellderived membrane vesicles, which, in principle, can be detected in all biological fluids as a result of membrane shedding by virtually any cell type in the organism, including bacteria. The first reports describing the existence of EVs can be dated back to 1946, with EVs defined as 'pro-coagulant platelet-derived particles' (Chargaff and West, 1946) . Peter Wolf later identified microparticles as inert product of platelets, referring to them as 'platelets dust' (Wolf 1967) . The interest in EVs biology grew in the 1970s-1980s, when independent studies could show that vesicles, in the order of nanometers, could be found in serum, seminal plasma and prostatic fluid (Benz et al., 1974 , Ronquist et al., 1978a , Ronquist et al., 1978b , Johnstone et al., 1987 . It took at least other two decades until studies on EVs were performed in the central nervous system (CNS), mostly focusing on development. Pioneering studies, carried on in Drosophila, identified membrane exovesicles, termed argosomes, as vehicle to spread morphogens through epithelia (Greco et al., 2001) . A role in tissue development and maintenance for extracellular membrane particles was also demonstrated in the developing embryonic mouse brain and in cultures of undifferentiated cortical neurons (Marzesco et al., 2005 , Fauré et al., 2006 , thus revealing new implications for EVs in modulating neuronal development and synaptic activity.
According to their size and origin, EVs can be divided into exosomes and microvesicles (MVs), with the latter being released by healthy cells or apoptotic bodies, originated by the shedding of membrane vesicles following apoptosis (Cocucci et al., 2009 , Théry et al., 2009 , György et al., 2011 , Colombo et al., 2014 .
The inter-cellular communication via secreted extracellular vesicles has been solidly established in the last two decades, and novel biological functions continue to be described, highlighting the importance of the functional cargoes transferred from one cell to another in physiological and pathological processes.
For instance, pro-peptides, cytosolic proteins, microRNAs and mRNAs have been reported as EVs content, ready for delivery to targeted recipient cells .
In the central nervous systems (CNS), cross-talk between glia and neurons is crucial for a variety of biological functions, ranging from brain development, neural circuit maturation, homeostasis maintenance. Glia cells not only dictate inflammatory responses upon infections or diseases, but they also provide constant neurotrophic support, and are implicated in remodeling and pruning synapses. Along with the classical direct cell-to-cell contact and the paracrine action of secreted molecules, glia and neurons can communicate by releasing and receiving extracellular vesicles, which allows a coordinated regulation across long distances (Lai and Breakfield, 2012 , Rajendran et al., 2014 , Budnik et al., 2016 , Kramer-Albers and Hill, 2016 . In particular, microglia, the innate immune cells of the CNS, largely rely on mobile-vesicles to propagate cytokines-mediated inflammatory response across distant brain regions (Fruhbeis et al., 2013) . Toxic protein aggregates such as -synuclein, tau and amyloid beta (A), and prionic pathogenic proteins have been also reported among the content of EVs (Schneider and Simons, 2013 , Rajendran et al., 2006 , Ngolab et al., 2017 , providing support for pathological implication of EVs exchange in neurodegenerative disorders.
Origin and functions of extracellular vesicles
Exosomes and microvesicles are cell-derived membrane vesicles that are secreted by a number of cells as a means of removing proteins and lipids, and releasing them in the extracellular space (Raposo and Storvoogel, 2013) . With the term 'exosomes' we specifically refer to vesicles that are derived through endocytosis, a process used by cells to internalise extracellular material as well as membrane proteins and lipids. During endocytosis, the plasma membrane invagination (outside-in) gives rise to early endosomes, the limiting membrane of which undergoes another round of invagination (inside-out) to form the intraluminal vesicles (ILVs), which give the endosome a multivesicular appearance. Multivesicular bodies harboring the ILVs can then fuse with the plasma membrane to release them as exosomes. Microvesicles, on the other hand, refer to all cell-derived vesicles including apoptotic bodies that originate from the plasma membrane. Microvesicles (MVs), of variable shape and size (0.1-1µm), originate by direct outward budding of the plasma membrane into the extracellular space. By contrast, exosomes are much smaller in size (30-100nm).
In both cases, the inside-out budding of these vesicles carry not only membraneassociated material but also a substantial portion of cytosol, thus also carry elements of inheritance. The outward budding of exosomal membranes can be regulated by the endosomal sorting complex required for transport (ESCRT), or by sphingomyelinase, in an ESCRT-independent manner (Trajkovic et al., 2008 , Stuffers et al., 2009 . Common markers used for identifying exosomes, such as CD63 and CD81 tetraspanins or components of the ESCRT complexes, such as TSG101 and ALIX, however, can also be found in MVs, making difficult to fully discriminate between exosomes and microvesicles.
The functions of EVs might largely underlie two major biological needs of the cell: liberating unneeded cytosolic material targeted for disposal into the extracellular space, or transferring specific biomolecules to other cells as an effective mean for intercellular communication. Supporting evidence for the latter came with the discovery, in the last decade, that EVs can contain functional mRNAs and microRNAs, which could be translated into proteins or could regulate transcripts once into recipient cells (Ratajczak et al., 2006 , Valadi et al., 2007 , Skog et al., 2008 , Mittelbrunn et al., 2011 , Montecalvo et al., 2012 . Since these vesicles have been shown to carry both mRNA and miRNA, they are construed to modulate gene expression even in cells that are remotely positioned in space, thus exerting a new endocrine-like mechanism.
Microglia in the healthy and in the diseased brain
Microglia are the tissue-resident macrophages of the CNS and thus represent the first line of defense against pathogens or threats to the brain homeostasis (extensively reviewed in Li and Barres, 2017 , Wolf et al., 2017 , Colonna and Butovsky, 2017 . They are key players in immune regulation, by producing soluble factors such as chemokines, cytokines, and free radicals, i.e. reactive oxygen species (ROS) and nitric oxide (NO), known to mediate inflammatory responses. Elegant fate-mapping studies have recently provided evidence that microglia originate from yalk sac-derived erythromyeloid progenitors, which then migrate into the neuroepithelium of the developing embryo (Ginhoux et al., 2010 , Kierdorf et al., 2013 . Microglia reside in the CNS as long-living cell population, and are capable of efficient self-renewal without the contribution of peripheral myeloid cells (Bruttger et al., 2015 , Tay et al., 2017 . Among all the resident cell types that compose the CNS, microglia are by far the most motile and dynamic, constantly expanding and retracting their processes to monitor the surrounding parenchyma. For long time microglia have been consideredmistakenly -to be resting cells, behaving as an army in stand-by: inactive as default but ready to respond in case of injuries. Only recently, live imaging of the healthy mouse brain revealed that microglia are restless cells, even in the absence of injuries, suggesting a crucial role in thoroughly scanning the surrounding environment and in monitoring the neighboring cells (Davalos et al., 2005; Nimmherjan et al., 2005) . The advent of novel genetic and imaging tools in the last decade has exponentially promoted the growth of microglia-related studies (Tremblay et al., 2015) . As a consequence, the number of physiological roles described for microglia is progressively increasing. Important functions have been demonstrated in supporting neurogenesis (Sierra et al., 2010 , Nikolakopoulou et al., 2013 , Ribeiro Xavier et al., 2015 , Sellner et al., 2016 and providing trophic support to neurons (Hoshiko et al., 2002 , Ueno et al., 2013 , Parkhurst et al., 2013 , Miyamoto et al., 2016 . Remodeling axonal tracts and synaptic connections are also accounted among the emerging physiological roles of microglia during development, overall contributing to the efficient maturation of neural circuits (Paolicelli et al., 2011 , Schafer et al., 2012 , Squarzoni et al. 2014 , Zhan et al., 2014 , Sipe et al., 2016 .
The discovery of microglia implication in the diseased brain boasts a much older history. Microglia were observed and described for the first time in a histopathology laboratory by Pio del Rio-Hortega, who proposed the name 'microglia' in 1919 (Sierra et al., 2016) . Since then, microglia were recognized as phagocytic cells rapidly reacting to injuries, thereby studied almost exclusively in pathological contexts. However, despite a large and established literature, the picture today remains quite complex, and many controversies about microglial function in pathology still need to be addressed. As the resident immune cells of the brain, microglia play a central role in responding to any threat to the homeostasis -from invading pathogens, to endogenous misfolded proteins or to malignant cells. In several cases, microglial response can significantly contribute to neurodegeneration by mediating aberrant loss of synaptic connections (Hong et al., 2016 , Lui et al., 2016 , Paolicelli et al., 2017 , Bialas et al., 2017 . In addition, microglia are major players in neuroinflammation, being the primary source of inflammatory mediators in the CNS, such as cytokines, reactive oxygen species and soluble lipids (Graeber and Rodriguez, 2011, Wang et al., 2015) . Although the ultimate goal of microglial-mediated neuroinflammation aims at solving the occurring injury and restoring brain homeostasis, the outcomes of such responses are not always beneficial, especially in the context of neurodegeneration, where chronic exposure to inflammatory stimuli can become neurotoxic. As a consequence of their various and complex roles, microglia critically contribute to brain homeostasis, and are now accepted as important modifiers of diseases.
Microglia-derived extracellular vesicles
In both physiological and pathological conditions, microglia communicate with neighbouring cells simultaneously by cell-to-cell contact, by release of soluble factors and via exchange of biomolecules through secreted vesicles.
Several studies have reported the existence of extracellular vesicles of macrophagic and microglial origin , Prada et al., 2013 , Garzetti et al., 2014 . Microvesicles released by microglia are usually variable in shape and can range from 100nm up to 1µm. Because of their long distance diffusivity, they represent an efficient way to modulate the activity of neighbouring microglial population as well as of different cell types in the surrounding. Microglia-derived EVs, for instance, critically regulate synaptic transmission, by promoting neuronal production of ceramide and sphingosine (Antonucci et al., 2012) . Such enhanced sphingolipid metabolism positively affects excitatory neurotransmission in vitro and in vivo, supporting a physiological modulation of synaptic activity by microglia (Antonucci et al., 2012) . One mechanism used my microglia-derived EVs to modulate presynaptic transmission is the endocannabinoid system. Indeed, EVs secreted by microglia carry the endocannabinoid N-arachidonoylethanolamine (AEA) on their surface.
AEA-bearing EVs stimulate type-1 cannabinoid receptors (CB1) expressed by
GABAergic neurons and inhibit presynaptic transmission (Gabrielli et al., 2015) .
Proteomic analyses have extensively characterized the protein content of microglia-derived exosomes, describing several enzymes, chaperones, tetraspanins, and membrane receptors, common to the profile of exosomes originated by B-cells and dendritic cells. Pioneering studies identified unique markers for microglia-derived exosomes, such as the aminopeptidase CD13 and the lactate transporter MCT-1 (Potolicchio et al., 2005) . It has to be considered, however, that biological activity and composition of EVs strictly depends on the state of donor cells, the extracellular stimuli and the downstream signaling pathways (Bernimoulin et al., 2009 . Extracellular ATP has been identified as a major stimulant for vesicles shedding in microglia, through the P2X7 receptors. Several reports indicate that ATP-induced microglial EVs are enriched in IL-1and GAPDH thus, promoting propagation and regulation of neuroinflammatory response in the brain (Bianco et al., 2005 , Takenouchi et al., 2015 . The release of vesicles loaded with functional P2X7 receptors, on the other hand, could represent an efficient strategy for microglia to reduce the presence of these receptors on the plasma membrane, decreasing P2X7-mediated apoptosis .
Interestingly, ATP has been recently shown to modify the content of MVs released by microglia, driving the enrichment in proteins implicated in cell adhesion/extracellular matrix organization, autophago-lysosomal pathway and cellular metabolism, which in turn affect the cellular response of recipient astrocytes (Drago et al., 2017) .
Despite the growing interest in the topic, little is known about the stimulation agents that can induce EVs shedding in microglia. Recent studies highlighted a role for serotonin, reporting that binding to specific serotonin receptors (5-HT2a,b and 5-HT4) can stimulate exosomes release via increase in cytosolic Ca 2+ , both in primary microglia cultures and BV2 cell line (Glebov et al., 2015) . Treating primary microglia with recombinant Wnt3 was also proved to increase exosomes secretion through a GSK3-independent mechanism (Hooper et al., 2012) . Interestingly, proteomic analyses revealed that Wnt3-induced microglia-derived exosomes were enriched in proteins associated with cellular metabolism, cellular architecture, protein synthesis, and protein degradation (Hooper et al., 2012) .
In case of infection, microglia are rapidly engaged as the first line of defense, and the arising pro-inflammatory response is usually directed at defeating the invading pathogens. Stimulation with lipopolysaccharide (LPS), a component of the wall of gram-negative bacteria, significantly increases microvesicles release in microglia, whose content is enriched in IL-1 proinflammatory cytokine and miR-155, a microRNA recently shown to drive proinflammatory responses (Jablonski et al., 2016 , Kumar et al., 2017 .
Interestingly, the microglia-derived exosomal content differs depending on the priming stimulus: for instance, LPS, a ligand for the Toll-like receptor (TLR)4, was found to induce GAPDH secretion in association with exosomes, but the same was not true for bacterial flagellin (a ligand for TLR5) (Takenouchi et al., 2015) . Microglia transfected with Nef, the negative factor of human immunodeficiency virus (HIV), release exosomes containing Nef, which disrupt integrity and permeability of the brain blood barrier (BBB) and promote microglial secretion of cytokines such as IL-6, IL-8, and IL-12 (Raymond et al., 2016) .
Neuroinflammation plays a critical role not only in cases of infections, but also upon traumatic brain injury (TBI), where -if aberrantly prolonged -it can mediate neuronal damage. In the acute and chronic phases following TBI, microglia are engaged in a complex inflammatory response. While recent studies show that microglia-derived extracellular vesicles released following TBI shift microglia towards an anti-inflammatory and tissue repair expression profile (Huang et al., 2018) , others report that they promote neuroinflammation (Kumar et al., 2017) . The apparent contradiction might be explained by different time course of microglial response and further investigations are warranted to clarify these aspects.
Microglia are critically implicated in the pathogenesis of neuropathic pain. A recent study showed that spinal nerve ligation induces shedding of microglia-derived microvesicles via activation of P2X7-p38 pathways (Li et al., 2017a) . The up-regulation of IL-1 contained in the MVs was associated with reduced paw withdrawal threshold (PWT) and paw withdrawal latency (PWL), thus supporting a direct effect of microglia-derived MVs on neuropathic pain (Li et al., 2017a) . TRPV1 channels, critical neuropathic pain biomarkers, have been shown to be highly expressed in cortical microglia in mice, and to promote microglial EVs shedding, with consequent regulation of neuronal glutamatergic transmission (Marrone et al., 2017) .
Microglia-derived EVs are also involved in neurodegenerative processes. For example, treatment of BV2 cell line with alpha-synuclein increases the secretion of EVs, which express higher surface levels of MHC class II molecules and TNF-α, and have a higher capacity to induce neuronal apoptosis (Chang et al., 2013) .
Microglial regulation by extracellular vesicles
In the complex context of multidirectionality of cell-to-cell communication, In a recent study, exosomes derived from hypoxia-preconditioned mesenchymal stromal cells ameliorated cognitive decline in a mouse model of AD, by rescuing synaptic dysfunction and modulating astrocytic and microglial activity, decreasing pro-inflammatory factors such as TNF- and IL-1 (Cui et al., 2017 ). As mentioned above, microglia contribute to the complex inflammatory reaction which follows TBI. EVs derived from stem cells of odontogenic origin, prevent M1 polarization of microglia in vitro, and attenuate the neuroinflammatory response in a rat model of TBI (Li et al., 2017b) . Microglia targeting using EVs is a promising therapeutic strategy for several CNS disorders associated with neuroinflammation, and further research is needed to identify the optimal cellular source and administration route to achieve the desired immunomodulatory effects of EVs. The peripheral immune system has profound effects on brain functions, and periphery-to-brain communication has been proposed to contribute to the pathophysiology of a number of CNS disorders.
Microglia targeting by systemic inflammation has been suggested to mediate the neuronal dysfunctions associated with inflammation (Perry and Teeling, 2013) .
Concomitantly, evidence exists for the contribution of EVs-mediated peripheryto-brain communication during inflammatory conditions (Ridder et al., 2014) .
Recent studies suggest microglia as brain target for circulatory EVs. Li et al. (2018) showed that serum EVs from LPS-challenged mice, upon systemic transfer to naïve mice, induce neuroinflammation and are taken up primarily by microglia, and to a lesser extent by neurons and astrocytes. Interestingly, when plasma EVs are injected directly in the brain they are preferentially taken up by microglia . Nonetheless, the routes used by systemic inflammation to transduce inflammatory signals to the brain via EVs are still poorly understood. It has been recently showed that choroid plexus epithelial cells (CPECs) respond to systemic inflammation by secreting higher numbers of EVs, which are enriched in pro-inflammatory miRNAs, and that are taken up by both astrocytes and microglia. In the brain parenchyma, CPECs-derived EVs from the CSF reach the brain parenchyma and activate an inflammatory program (Balusu et al., 2016) . It is therefore possible that systemic inflammation stimulates the release of inflammatory EVs by peripheral immune cells, which could directly cross the blood-brain-barrier (BBB), and target brain cells.
Alternatively, other cells types, such as epithelial cells, might be needed to act as intermediary, by responding to the systemic milieu (including circulating inflammatory EVs), with the release of EVs. Once in the parenchyma, epithelial cells-derived EVs can be taken up by brain cells, including microglia, astrocytes and neurons (Balusu et al., 2016; Li et al., 2018; Ridder et al., 2014) . Further studies are needed to decipher the mechanisms used by EVs to transduce systemic signals to the brain both under physiological and pathological conditions. Notwithstanding their usage as potential biomarkers, the fascinating biology behind their formation remained thus far elusive. While misfolding and exposure of hydrophobic residues could nucleate the aggregation process, studies show the involvement of several membrane lipids to accelerate the process. Lipids such as phosphatidylserine (PS), ceramide, and ganglioside seem to increase amyloid formation. Incidentally, most of these lipids are found in exosomes (Skotland et al., 2017) , thus making exosomes possible candidates for amyloid formation.
EVs and microglia in neurodegenerative diseases
In the case of Alzheimer's disease, it has been shown that both A40 and A42, the species involved in the formation of amyloid, are present in exosomes (Rajendran et al, 2006) . The exosomes containing A seem to arise from endocytic compartments, as the authors show that the intracellular A localizes to structures reminiscent of MVBs and that both -and the -cleavages of the substrate amyloid precursor protein (APP) have been localized to early and lateendosomal compartments. Altogether, these findings indicate exosomal vesicles to be of endocytic origin (Rajendran et al., 2006; Vella et al., 2008) . Thus neuronal endosomes and exosomes could contribute to production and release of A respectively. Microglia cells on the other hand, have been shown to modulate A clearance by its internalization and degradation. While overproduction of A due to mutations in APP and the -secretase catalytic subunit could result in the early onset AD, late-onset AD -that affects an overwhelming 98% of the population -is thought to occur due to defective clearance of A. Impaired removal of amyloid could result from defective microglia-mediated degradation or defective A efflux in the interstitial fluid.
Incidentally, exosomes released by neurons are enriched in glycosphingolipids that could sequester A, and that in turn could be taken up my microglia (Yuyama et al., 2015) . Yuyama and colleageues recently demonstrated that flooding the brain with exosomes enriched with glycosphingolipids could indeed reduce amyloid load, by acting as a potent A scavenger, and thus promoting microglia uptake and consequent intracellular degradation (Yuyama et al., 2012 , Yuyama et al., 2014 . Another mechanism by which microglial-derived exosomes have been shown to promote amyloid clearance is through the activity of exosome-associated insulin degrading enzyme (IDE), a zinc metallopeptidase known to efficiently degrade A (Tamboli et al., 2010) . In particular, statins, a class of lipid-lowering medications, which inhibit HMG-CoA reductase, were identified as a potent stimulant of microglial secretion of IDE, through extracellular vesicles (Tamboli et al., 2010) .
While some studies have reported beneficial roles for microglia-derived extracellular vesicles in clearing toxic proteins, others have highlighted their association with neuronal and synaptic damage. Microglia-derived MVs isolated from rat primary cultures were shown to promote formation of soluble forms of A, thus enhancing neurotoxicity when administered to cultured hippocampal neurons (Joshi et al., 2014) . Similar neurotoxic effects were observed when microglia-derived MVs were isolated from the cerebrospinal fluid (CSF) of patients with mild cognitive impairment (MCI) or AD (Joshi et al., 2014) . MVs of myeloid origin in the CSF of AD and MCI-converting-to-AD patients were found to be significantly more abundant than in healthy controls and MCI notconverting-to-AD, and were associated with white matter and neuronal loss, suggesting that microglial MVs are neurotoxic and myelinotoxic in the presence of excessive amyloid (Agosta et al., 2014) . In addition, inflammatory microglia have been recently described to release EVs enriched in miRNAs capable to regulate the level of synaptic proteins in the recipient neurons, leading to loss of excitatory synapses, thus providing evidence for a novel mechanism, by which microglial-derived MVs could mediate synaptic alterations in neurodegeneration (Prada et al., 2018) .
Microglia-associated exosomes seem to play a role not only in the regulation of synaptic proteins and A levels, but also in the spread of tau pathology. Using two different AD mouse models, it was recently shown that tau, a neuronal protein associated with microtubules and abnormally accumulated in degenerating neurons, was selectively taken up by microglia and not by astrocytes. In addition, microglia also released the engulfed tau in association with exosomes, which then were taken up by cortical neurons, thus aiding the spread of tau pathology. Depleting either microglia or exosome production resulted in reduced spread of mutant tau (Asai et al., 2015) . Recent data support the idea that exosomes do participate in tau transmission by demonstrating that some amount of Tau is released from neurons via exosomes, in part, via synaptic activity , confirming earlier findings (Saman et al., 2012 , Pooler et al., 2013 , Medina and Avila, 2014 .
These studies once again highlight the role of synaptic activity in AD pathology. Exosomes do not play a role only in the release and cell-to-cell transmission of tau; new data show that extracellular vesicles isolated from tau transgenic mouse brains could enhance seeding of Tau pathology when injected into wildtype mice (Polanco et al., 2016) . The reasons why these vesicles could aid in seeding are less clear; in particular, it would be important to investigate why the tau found in extracellular vesicles is differentially or hypo-phosphorylated (Polanco et al., 2016 .
One possible explanation could be that exosomes, perhaps those that contain amyloid proteins, inner or outer leaflet of exosomes, have a different lipid composition that can modulate microglial clearance capacity (Yuyama et al., 2012 , Yuyama et al., 2014a Yuyama et al., 2014b) or enhance amyloid aggregation process (Rajendran et al., 2007 , Rajendran et al., 2014 . Indeed, oligomerization of Aβ has been shown to be accelerated in the presence of lipids that are found in exosomes such as ceramide and gangliosides (Yanigisawa 2007 , Ikeda et al., 2011 , Hoshino et al., 2013 , Hong et al., 2014 , Takasugi et al., 2015 , Yanagisawa et al., 2015 .
Interestingly, inhibition or deletion of neutral sphingomyelinase not only reduces tau pathology (Asai et al., 2015) as discussed before but also reduces Aβ pathology adding support to this hypothesis (Dinkins et al., 2014 , Dinkins et al., 2016 .
These results altogether unequivocally demonstrate that microglia and microglia-derived exosomes, with their broad range of neurotoxic and neuroprotective roles, critically contribute to the pathogenesis of Alzheimer's disease.
Conclusion
The last decades have witnessed an exponential growth of knowledge in the field 
Microglia as recipient cells for EVs of different origin:
1. glioblastoma-derived EVs contain metalloproteases that modulate microglial function; 2. oligodendrocytederived EVs are targeted to microglia for clearance; 3. Neuron-derived EVs containing C3 can promote synaptic pruning; amyloid-beta and tau containing EVs can be taken up by microglia. 4. Circulatory EVs preferentially target microglia in the CNS. Microglia as source of EVs: ATP-dependent release of EVs, shown to contain miRNAs and cytokines, target (5.) neurons and (6.) astrocytes. A number of others stimulation agents have been described to promote EVs shedding from microglia. See text for details.
